However, these potential new treatment avenues do not take into account CD154 interactions with its recently discovered receptors belonging to the integrin family, which could also be highly involved in SLE pathogenesis and constitute important targets for therapeutic approaches. This evidence concerns the gene CD40LG and systemic lupus erythematosus.